Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIONS trial of citalopram augmentation for persistent negative symptoms in schizophrenia
2009-009235-30Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of citalopram in schizophrenia (2 arms), sponsored by Imperial College London. Primary endpoints: Quality of life at 3 months, Quality of life over 12 months and 1 more. Started Oct 2009; status: completed.
02
Drugs
citalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-009235-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009235-30.